Higher GARS1 mRNA levels correspond to significantly worse survival in five different cancer types (BLCA, KIRC, LGG, LIHC, and LUAD) compared to only one for KARS1 (HNSC) (Figure 4). Here, GARS1 is linked to bladder transitional cell carcinoma.